You are here: Fairness.com > Resources > Dr. Jeffrey P. Kahn Ph.D.

Dr. Jeffrey P. Kahn Ph.D.


Self Description

December 2011: "Jeffrey Kahn is Deputy Director for Policy and Administration at the Johns Hopkins University Berman Institute of Bioethics, a position he assumed in August 2011.  Prior to joining the faculty at Johns Hopkins, Prof. Kahn was Director and Professor in the Center for Bioethics at the University of Minnesota, positions he held from 1996-2011.  He works in a variety of areas of bioethics, exploring the intersection of ethics and health/science policy, including research ethics, ethics and public health, and ethical issues in leading edge biomedical technologies.  He has published three books and over 100 articles in the bioethics and medical literature.  His education includes a BA from UCLA (molecular biology), PhD from Georgetown University (philosophy (bioethics)), and MPH from Johns Hopkins University School of Public Health (health policy). Dr. Kahn serves on numerous state and federal advisory panels, including committees for the Institute of Medicine, National Institutes of Health, and others.  He is an elected Fellow of the Hastings Center, and speaks frequently across the U.S. and around the world on a range of bioethics topics.  From 1998-2002 he wrote the bi-weekly column Ethics Matters on CNN.com, and was founding president of the Association of Bioethics Program Directors, a position he held from 2006-2010."

http://www.bioethicsinstitute.org/mshome/?ID=148

Third-Party Descriptions

December 2011: 'Actual decisions about research grants will be every bit as complicated as this. Who is doing the deciding and how the rules are written will make all the difference in when and if chimps are used in experiments. The chairman of the Institute of Medicine committee, Jeffrey Kahn, a bioethicist at Johns Hopkins, said this was essentially a “disagreement about facts,” about the science, not about what the policy should be. But it was also about what the language meant.'

http://www.nytimes.com/2011/12/20/science/recognition-of-chimps-as-relatives-may-reshape-research.html

May 2009: 'Jeffrey P. Kahn, a University of Minnesota bioethicist, sees “value in demystifying medical care,” but said this “creates an aura of sophistication and high-tech ability” that may not represent “quality of care at a hospital.”'

http://www.nytimes.com/2009/05/25/health/25hospital.html

Relationships

RoleNameTypeLast Updated
Organization Head/Leader (past or present) Berman Institute of Bioethics Organization Dec 20, 2011
Student/Trainee (past or present) Georgetown University Organization Dec 20, 2011
Employee/Freelancer/Contractor (past or present) Hastings Center Organization Dec 20, 2011
Student/Trainee (past or present) Employee/Freelancer/Contractor (past or present) Johns Hopkins University (JHU) Organization Dec 20, 2011
Student/Trainee (past or present) University of California - Los Angeles (UCLA ) Organization Dec 20, 2011
Employee/Freelancer/Contractor (past or present) University of Minnesota Organization May 27, 2009

Articles and Resources

Date Fairness.com Resource Read it at:
Dec 19, 2011 Elevation of the Chimp May Reshape Research

QUOTE: When Dr. Francis S. Collins, the head of the National Institutes of Health, announced Thursday that the government would halt all new grants for research on chimpanzees....N.I.H. is the source of a river of money that flows into labs around the country where animals in the millions are, to misuse the words of an old Arlo Guthrie song, “injected, inspected, detected, infected” and a few other things, all in the cause of increasing knowledge and alleviating human suffering, of course.

 New York Times
May 24, 2009 Webcast Your Brain Surgery? Hospitals See Marketing Tool

QUOTE: Seeking to attract or educate patients, entice donors, gain recognition and recruit or retain top doctors, hospitals are using Twitter from operating rooms, showing surgery on YouTube and having patients blog about their procedures....Some ethicists and physicians say the practices raise questions about patient privacy and could paint overly-rosy medical pictures, leaving the hospitals and patients vulnerable if things go awry.

 New York Times